Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral propranolol on benign vascular tumors in children under 15 years
IRCT2015011920715N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propranolol in hemangioma and Benign vascular tumor of the skin, sponsored by Arak University of Medical Sciences. Started Oct 2014; status: completed.
02
Drugs
propranolol
03
Conditions
hemangiomaBenign vascular tumor of the skin
Beyond the preview
Go deeper on IRCT2015011920715N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015011920715N1.